Work Here?
Industries
Biotechnology
Healthcare
Company Size
201-500
Company Stage
Series C
Total Funding
$224.3M
Headquarters
New York City, New York
Founded
2014
Opentrons provides affordable and user-friendly laboratory automation solutions, primarily targeting the biotechnology and life sciences sectors. Their main product, the OT-2, is a liquid handling robot that automates repetitive tasks like pipetting, which involves transferring liquids between containers. Opentrons sells these robotic systems along with complementary software and consumables, generating revenue through direct hardware sales and subscriptions for software. What sets Opentrons apart from competitors is its focus on making automation accessible to smaller labs and institutions that may not afford traditional, expensive systems. Their products are designed for easy setup and use, lowering the barriers for labs to adopt automation technology. The goal of Opentrons is to transform laboratory automation by providing cost-effective and user-friendly solutions that cater to a diverse range of clients.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$224.3M
Above
Industry Average
Funded Over
3 Rounds
Industry standards
Opentrons releases no-code robot for pipetting tasks. By The Robot Report Staff | September 15, 2024Listen to this articleOpentrons’ Flex Prep robot can perform pipetting tasks such as sample reformatting, plate prep, dilutions, concentration normalization, cherry-picking, and more. | Source: Opentrons. Opentrons Labworks, Inc. launched its Flex Prep robot this week. It’s paired with new no-code software that allows users to set up pipetting tasks and execute that workflow all through a touchscreen
Opentrons introduces Flex Prep: A no-code robot offering the simplicity of a pipette with the versatility of a liquid handler.
BROOKLYN, N.Y.--(BUSINESS WIRE)--Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics, today announced the launch of Opentrons® for Education, an exclusive offering for educators to bring lab automation to the classroom. Opentrons is building a first-of-its-kind ecosystem for teaching with automation, which includes education pricing and support, along with access to a community of educators already teaching with Opentrons. Our goal is to make lab automation a universal skill. Bringing lab automation to the classroom gives students a competitive advantage for their careers by addressing the growing skill gap faced by biotech companies. Opentrons for Education is the key to unlocking a new era of hands-on, innovative learning in the realm of laboratory sciences. "The life sciences industry has been slow to adopt lab automation due to the precision required to manipulate precious samples and reagents at milliliter and microliter volumes, and the lack of skilled personnel to introduce automated workflows into labs
BROOKLYN, N.Y.--(BUSINESS WIRE)--Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics, today announced the appointment of Gregory Cole, PhD as Chief Innovation Officer. With over a decade of medical robotics, IP strategy, and product commercialization expertise, Dr. Cole will be responsible for establishing commercial and academic partnerships with leading research institutions and biopharma companies and creating novel product solutions for the company’s Opentrons Flex, the first liquid-handling robot designed to be compatible with “design-of-experiment” programs, including AI-driven agents utilizing large language models (LLMs). "Greg's remarkable experience underscores his proficiency in steering robotic technologies towards successful commercialization," said Jonathan Brennan-Badal, CEO of Opentrons. "With a proven history of advancing medical robotics and fostering corporate partnerships, he will play a pivotal role in driving the continued global reach of Opentrons Flex and delivering innovative automated solutions to life science researchers. We welcome Greg to the Opentrons family."
OpenTrons also launched a generative AI tool and protocol library to help researchers automate experimental workflows.
Find jobs on Simplify and start your career today
Industries
Biotechnology
Healthcare
Company Size
201-500
Company Stage
Series C
Total Funding
$224.3M
Headquarters
New York City, New York
Founded
2014
Find jobs on Simplify and start your career today